Cutis marmorata telangiectatica congenita: clinical features in 35 cases.

Cutis marmorata telangiectatica congenita: clinical features in 35 cases. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Cutis marmorata telangiectatica congenita: clinical features in 35 cases. Abstract Text:

OBJECTIVE: To evaluate the distribution of skin lesions, clinical features, and associated abnormalities in children with cutis marmorata telangiectatica congenita at onset and during follow-up. DESIGN: Retrospective survey of the available medical data with an average follow-up of 1 year 5 months (range, 0-7 years). SETTING: Pediatric Dermatology Unit (Department of Dermatovenereology) of the Sophia Children's Hospital in Rotterdam, the Netherlands. PATIENTS: The diagnosis of cutis marmorata telangiectatica congenita was clinically established in 35 patients between July 1988 and February 1997. In 33 cases, the typical mottled, blue-violet pattern was present from birth and was readily visible at rest. In 2 cases, the skin lesions initially appeared less reticulated, mimicking a capillary malformation. RESULTS: The skin lesions were almost generalized in 4 children (11%), whereas they were more localized in the other 31 children (89%). Associated anomalies, usually minor and sometimes questionable, were noted in 80% of the patients. Most patients showed a definite improvement of their mottled vascular skin lesions within 2 years. The lesions had totally disappeared, or only faded residual lesions remained. CONCLUSIONS: We believe that cutis marmorata telangiectatica congenita is a relatively mild condition. The prognosis is usually good, with minor associated anomalies. Improvement of the mottled, vascular pattern is usually observed within 2 years. We recommend careful clinical examination of all patients to exclude any associated anomalies. Patients should be referred to a neurologist or an ophthalmologist only if symptoms are present or if vascular lesions are present around the eyes.

Cutis marmorata telangiectatica congenita: clinical features in 35 cases. Publishing Authors By Initials

For similar cardiovascular diseases: vascular diseases: telangiectasis research abstracts see: cardiovascular diseases: vascular diseases: telangiectasis research

PUBMED ID PMID:

MEDLINE DATE:

Cutis marmorata telangiectatica congenita: clinical features in 35 cases. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Archives of dermatology

VOLUME: 135

Page Numbers: 34-8

Journal Abbreviation: Arch Dermatol

ISSN: 0003-987X

DAY: 17

MONTH: Jan

YEAR: 1999

Cutis marmorata telangiectatica congenita: clinical features in 35 cases. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 372433

Cutis marmorata telangiectatica congenita: clinical features in 35 cases. Keywords Mesh Terms:

KEYWORDS: Telangiectasis

MESH TERMS: pathology

Chemical & Substance for Abstract: Cutis marmorata telangiectatica congenita: clinical features in 35 cases. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Cutis marmorata telangiectatica congenita: clinical features in 35 cases.

AFFILIATION: Department of Dermatovenereology, University Hospital Rotterdam, The Netherlands.

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Arch Dermatol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Cutis marmorata telangiectatica congenita: clinical features in 35 cases Related Publications

• Allergic contact dermatitis to chlorhexidine and para-amino compounds in a 4-year-old boy: a very rare observation.
• Atopy patch tests with aeroallergens in children aged 0-3 years with atopic dermatitis.
• Contact dermatitis.
• Cutis marmorata telangiectatica congenita: clinical features in 35 cases.
• Development of atopic dermatitis in mice transgenic for human apolipoprotein c1.
• Development of childhood eczema and its classification.
• Efficacy and safety of retapamulin ointment as treatment of impetigo: randomized double-blind multicentre placebo-controlled trial.
• Prevalence of atopic dermatitis in children younger than 4 years in a demarcated area in central Netherlands: the West Veluwe Study Group.
• Soluble E-selectin and soluble ICAM-1 levels as markers of the activity of atopic dermatitis in children.
• [Diagnostic image (388). A boy with blue ears]